Epidemiology of Worsening Heart Failure in a Population-based Cohort from Alberta, Canada: Evaluating Eligibility for Treatment With Vericiguat

Ambrosy, 2014, The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries, J Am Coll Cardiol, 63, 1123, 10.1016/j.jacc.2013.11.053 Okumura, 2016, Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial (PARADIGM-HF), Circulation, 133, 2254, 10.1161/CIRCULATIONAHA.115.020729 Skali, 2014, Prognosis and response to therapy of first inpatient and outpatient heart failure event in a heart failure clinical trial: MADIT-CRT, Eur J Heart Fail, 16, 560, 10.1002/ejhf.71 Velazquez, 2018, Angiotensin–neprilysin inhibition in acute decompensated heart failure, N Engl J Med, 380, 539, 10.1056/NEJMoa1812851 McMurray, 2014, Angiotensin–neprilysin inhibition versus enalapril in heart failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077 McMurray, 2019, Dapagliflozin in patients with heart failure and reduced ejection fraction, N Engl J Med, 381, 1995, 10.1056/NEJMoa1911303 Packer, 2020, Cardiovascular and renal outcomes with empagliflozin in heart failure, N Engl J Med, 383, 1413, 10.1056/NEJMoa2022190 Armstrong, 2020, Vericiguat in patients with heart failure and reduced ejection fraction, N Engl J Med, 382, 1883, 10.1056/NEJMoa1915928 Ezekowitz, 2021, Participation in a heart failure clinical trial, Circ Heart Fail, 14, 10.1161/CIRCHEARTFAILURE.120.008242 Butler, 2021, Representativeness of the VICTORIA trial population in clinical practice: analysis of the PINNACLE registry, J Card Fail, 27, 1374, 10.1016/j.cardfail.2021.06.019 Bakal, 2014, Heart failure re-admission: measuring the ever shortening gap between repeat heart failure hospitalizations, PLoS One, 9, 10.1371/journal.pone.0106494 Ezekowitz, 2011, Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?, Eur J Heart Fail, 13, 142, 10.1093/eurjhf/hfq185 Quan, 2005, Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data, Med Care, 43, 1130, 10.1097/01.mlr.0000182534.19832.83 Frolova, 2015, Assessing the use of International Classification of Diseases-10th revision codes from the emergency department for the identification of acute heart failure, JACC Heart Fail, 3, 386, 10.1016/j.jchf.2014.11.010 Quan, 2009, Validation of a case definition to define hypertension using administrative data, Hypertension, 54, 1423, 10.1161/HYPERTENSIONAHA.109.139279 Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 Schneeweiss, 2003, Improved comorbidity adjustment for predicting mortality in Medicare populations, Health Serv Res, 38, 1103, 10.1111/1475-6773.00165 Ezekowitz, 2017, Comprehensive update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure, Can J Cardiol, 33, 1342, 10.1016/j.cjca.2017.08.022 Sepehrvand, 2016, Factors associated with natriuretic peptide testing in patients presenting to emergency departments with suspected heart failure, Can J Cardiol, 32, 986, 10.1016/j.cjca.2015.11.019 Rørth, 2020, Comparison of BNP and NT-proBNP in patients with heart failure and reduced ejection fraction, Circ Heart Fail, 13, 10.1161/CIRCHEARTFAILURE.119.006541 Butler, 2020, Clinical and economic burden of chronic heart failure and reduced ejection fraction following a worsening heart failure event, Adv Ther, 37, 4015, 10.1007/s12325-020-01456-1 Dunbar, 2021, Patient-centered outcomes in HFrEF following a worsening heart failure event: a survey analysis, J Card Fail, 27, 877, 10.1016/j.cardfail.2021.05.017 Alsumali, 2021, Budget impact analysis of vericiguat for the treatment of chronic heart failure with reduced ejection fraction following a worsening event, Adv Ther, 38, 2631, 10.1007/s12325-021-01681-2 Lim, 2021, Generalisability of randomised controlled trials in heart failure with reduced ejection fraction, Eur Heart J Quality of Care and Clinical Outcomes, qcab070 Fonarow, 2008, Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF, Circ Heart Fail, 1, 98, 10.1161/CIRCHEARTFAILURE.108.772228 Albert, 2017, Pharmacotherapy choice is associated with 2-year mortality for patients with heart failure and reduced ejection fraction, Adv Ther, 34, 2345, 10.1007/s12325-017-0618-4